Skip to content

Role of Panchajeeraka Guda in reducing symptoms of Udavartini Yonivyapada.

Add on effect of Panchajeeraka Guda in the management of Udavartini Yonivyapada with special reference to Primary Dysmenorrhea -A Randomized Controlled Clinical Trial - NIL

Status
Recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/08/092432
Enrollment
46
Registered
2025-08-05
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N944- Primary dysmenorrhea

Interventions

None listed

Sponsors

Dr Isha
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patients fulfilling the diagnostic criteria. 2) 15 to 25 years of age. 3) Painful menstruation for at least 3 consecutive cycles. 4) Regular menstrual cycles ranging from 21 to 35 days. 5) With average amount of menstrual flow. 6) Basti Yogya. 7) Willing to participate in the study.

Exclusion criteria

Exclusion criteria: 1) Diagnosed patients of secondary dysmenorrhea or with pelvic pathology (Eg-Endometriosis, fibroids, pelvic inflammatory disease etc.) 2) With irregular menstrual cycles. 3) Patients with systemic diseases like Diabetes, Hypertension, Thyroid dysfunction, Malignancy etc. 4) HIV, VDRL, HBsAG positive Patients. 5) Women using intrauterine contraceptive devices. 6) Lactating women.

Design outcomes

Primary

MeasureTime frame
Significant reduction in pain intensity associated with Udavartini Yonivyapada in the group receiving Panchajeeraka Guda and Tila Taila Matra Basti as compared to the Group receiving Tila Taila Matra Basti Alone.Timepoint: 0 th day, 2nd Month Menstrual cycle, 3rd Month Menstrual cycle

Secondary

MeasureTime frame
1. The Combined Therapy (Panchajeeraka Guda & Tila Taila Matra Basti) will Show a greater reduction in associated Symptoms Compared to Tila Taila Matra Basti. 2. The therapy will be safe, Well tolerated & may suggest a synergistic effect of oral and rectal routes in managing Udavartini YonivyapadaTimepoint: 0th day, 2nd Month Menstrual cycle, 3rd Month Menstrual cycle

Countries

India

Contacts

Public ContactDr Gayatri Hubli

KAHERS Shri B M Kankanawadi Ayurveda Mahavidyalaya Post Graduate Studies and Research Centre

drboradevi13@gmail.com8970216099

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026